COMBINATION THERAPY FOR PI3K-ASSOCIATED DISEASE OR DISORDER

ORGANIC COMPOUNDS

SELECTIVE AND NON-SELECTIVE OPIOID RECEPTOR FUNCTIONAL ANTAGONISTS AND METHODS RELATED THERETO FOR TREATMENT OF ADDICTION, OPIOD DEPENDENCE, AND NEUROPATHIC PAIN

HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS

PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO

COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS

SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES

Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor

RAPAMYCIN ANALOGS AND USES THEREOF

Antibacterial Compounds

BROMOCRIPTINE FORMULATIONS

RAPAMYCIN ANALOGS AND USES THEREOF

METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS

SOFT CHEWABLE FORMULATIONS WITH ACTIVE INGREDIENTS

SHP2 PHOSPHATASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME

NOVEL METHODS

METHODS OF TREATING HIDRADENITIS SUPPURATIVA

Methods for the preparation of biologically active compounds in nanoparticulate form

SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES

Amorphous solid dispersions

METHOD FOR PREVENTING OR TREATING DISEASE OR CONDITION ASSOCIATED WITH ANTITUMOR AGENT

Phosphodiesterase Inhibitor Treatment

NOVEL USES

Treatment Regimen

INTRANASAL DHE FOR THE TREATMENT OF HEADACHE

KRAS G12C INHIBITOR DOSING REGIMENS

DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY

COMPOSITION AND METHOD FOR TREATING COVID-19

Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

AMIDO-SUBSTITUTED PYRIDYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES

Methods for Treating HCV

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF COMPOUNDS THAT PROTECT AGAINST LIPOFUSCIN CYTOTOXICITY

PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE

Solid Pharmaceutical Compositions for Treating HCV

Methods

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

METHODS FOR TREATING SMALL CELL LUNG CANCER AND OTHER NEUROENDOCRINE CANCERS

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

METHODS OF MONITORING INFLAMMATORY BOWEL DISEASES

cGAS antagonist compounds

METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors

OVARIAN CANCER VACCINES

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

TYPE I DIABETES THERAPY

NOVEL METHODS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS

HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES

NOVEL METHODS

PHARMACEUTICAL COMPOSITIONS OF SITAGLIPTIN

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINATION WITH KINASE INHIBITORS

TRANSMUCOSAL METHODS FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

PHARMACEUTICAL COMPOSITIONS OF NILOTINIB

RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS

Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

AMORPHOUS SOLID DISPERSIONS

PED5 INHIBITOR SEMI-SOLID COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

TREATMENT OF DERMATOLOGICAL CONDITIONS

METHODS FOR TREATING DISEASES MEDIATED BY GLUTATHIONE PEROXIDASE 4

THERAPIES FOR CANCER USING SMALL MOLECULES THAT BIND TO AND INHIBIT RAIL INTERACTING PROTEINS

METHODS OF TREATING DISEASES AND DISORDERS

DOSING REGIMEN

Use of cannabidiol in treatment of pulmonary hypertension

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

RIFT VALLEY FEVER SMALL MOLECULE TREATMENT

Antiviral Prodrugs and Pharmaceutical Compositions Thereof

PHARMACEUTICAL COMPOSITIONS WITH LOW AMOUNTS OF NITROSAMINE IMPURITIES AND METHODS FOR PRODUCING THE SAME

Liquid oral formulations for sildenafil

Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders

THIONOESTER-DERIVATIVE OF RABEXIMOD FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS

METHODS AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES

COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Treatment of erectile dysfunction and other indications

Inhaled PDE-V Inhibitor Drugs

NOVEL METHODS

TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR

PALATABLE FORMULATIONS

Aryl Glucoside Derivative

METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION

TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB

COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

METHOD OF PREPARING NANOPARTICLES COMPRISING POORLY WATER SOLUBLE DRUGS FOR TREATING HEPATITIS

COMBINATIONS OF 15-PGDH INHIBITORS WITH CORTICOSTEROIDS AND/OR TNF INHIBITORS AND USES THEREOF

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS

N-methyl-D-aspartic Acid Receptor Modulators

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Organic compounds

Small molecule inhibitors of cancer stem cells and mesenchymal cancer types

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BTK AND MUTANTS THEREOF

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF

KRAS Gl2C INHIBITORS

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

Treatment of Cancer with TOR Kinase Inhibitors

PARENTERAL UNIT DOSAGE FORM OF DIHYDROERGOTAMINE

USE OF CANNABINOIDS IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE SEXUAL DYSFUNCTION

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

HETEROCYCLIC GLP-1 AGONISTS

4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS

Substituted indole Mcl-1 inhibitors

Antiproliferative compounds and second active agents for combined use

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF

Bromocriptine formulations

COMBINATION OF CABOTEGRAVIR AND LEVONORGESTREL

METHODS AND MATERIALS FOR INHIBITING NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE ACTIVITY

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS

METHODS AND MATERIALS FOR INCREASING NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE ACTIVITY

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Transmucosal methods for treating psychiatric and neurological conditions

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

ANTAGONIST COMPOUNDS

Composition and Method for Treating Metabolic Disorders

Heating unit for use in a drug delivery device

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

Liquid oral formulations for tadalafil

Combination methods and compositions including sleep therapeutics for treating mood

PHARMACEUTICAL FORMULATIONS COMPRISING TADALAFIL

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS

FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS

ANTIDIABETIC PHARMACEUTICAL COMPOSITIONS

CHEWABLE FORMULATIONS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof

Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders

LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF

DETERMINATION OF NFKB PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

COMBINATION OF A BTK INHIBITOR AND AN INHIBITOR OF CDK9 TO TREAT CANCER

COMPOSITE FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN AND PREPARATION METHOD THEREFOR

Method of Injecting Dihydroergotamine Into The Body

PYRROLO[2,3-B]PYRAZINE COMPOUNDS AS CCCDNA INHIBITORS FOR THE TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORS

Fused Azole Heterocycles as AHR Antagonists

METHOD OF ADMINISTERING UPADACITINIB TO AVOID ADVERSE DRUG INTERACTIONS AND EFFECTS

USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF MEDICAMENT FOR RESISTING FIBROTIC DISEASES

METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Compositions and use of varenicline for treating dry eye

Compositions and use of varenicline for treating dry eye

Compositions and use of varenicline for treating dry eye

METHOD OF ACHIEVING HIV VIRAL REMISSION USING LONG-ACTING ANTIRETROVIRAL AGENTS

ACALABRUTINIB MALEATE DOSAGE FORMS

NEW USE OF RABEXIMOD

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors

SUBSTITUTED PYRIDINES AND METHODS OF USE

Process for preparing substituted pyrazolo[1,5-a]pyrazines

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Organic compounds

COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY

COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY

LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA

AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)

THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]- pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

USE OF SELECTIVE GABA A ALPHA 5 NEGATIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS

STABLE COMPOSITIONS OF VARENICLINE

Organic compounds

USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

APICAL SODIUM-DEPENDENT TRANSPORTER INHIBITOR COMPOSITIONS

OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOF

RADIO-AND CHEMO-PROTECTIVE COMPOUNDS

Methods for the prophylaxis and treatment of COVID and COVID-19

USE OF CYCLO-HISPRO (CHP) FOR LOWERING BLOOD PRESSURE

Compounds and compositions for treating conditions associated with APJ receptor activity

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor

METHODS OF USING MYT1 INHIBITORS

Composition and Method for Treating Metabolic Disorders

METHODS OF TREATING RELAPSING MULTIPLE SCLEROSIS USING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN

COMPOSITIONS OF STABLE FORMULATIONS OF VARENICLINE SALT OR BASE FORM WITH CONTROL ON NITROSO IMPURITIES

Oral compositions and the preparation methods thereof

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND METABOLIC DISEASES ASSOCIATED THEREWITH

Inhibitors of Human Herpesviruses

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE

NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION

Methods of measuring signaling pathway activity for selection of therapeutic agents

CDK2 inhibitors and methods of using the same

REGIMENS FOR TREATING HIV INFECTIONS AND AIDS

THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

Chemokine CXCR4 Receptor Modulators and Uses Related Thereto

TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS

Heterocyclic inhibitors of PTPN11

THERAPEUTIC AGENT FOR TAUOPATHIES

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

TREATMENT OF CANCER WITH SMG1-INHIBITORS

SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NK/T-CELLLYMPHOMA OR NK-CELL LEUKEMIA, COMPRISING PHOSPHODIESTERASE TYPE 5 INHIBITOR

CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER

Compositions for Inhibition of Herpesviruses

COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF

COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES

POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR

ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS

POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES

NOVEL PROCESS FOR THE PREPARATION OF ACALABRUTINIB AND ITS INTERMEDIATES

ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF

PDE5 compositions and methods for immunotherapy

DOSAGES AND METHODS FOR TREATING PULMONARY ARTERIAL HYPERTENSION WITH RODATRISTAT

COMPOUNDS

KRAS G12C INHIBITOR AND PHARMACEUTICAL USE THEREOF

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

MOLECULAR TARGETS FOR ADDICTION

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

DISUBSTITUTED ALKYNE DERIVATIVES

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2

Oral film formulation for modulating absorption profile

Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer

PHARMACEUTICAL COMPOSITIONS COMPRISING CABOTEGRAVIR

Pyrazolo[1,5-a]pyrazin-4-yl derivatives

TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES

Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors

SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF

DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES

Substituted indole Mcl-1 inhibitors

NK-3 RECEPTOR ANTAGONISTS FOR THERAPEUTIC OR COSMETIC TREATMENT OF EXCESS BODY FAT

COMPLEX FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN, AND PREPARATION METHOD THEREFOR

METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSION

THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION

GLP-1R MODULATING COMPOUNDS

Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension

NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME

Sleep improving agent

GRANULES AND PREPARATION USING SAME

Antibacterial compounds

COMPOUNDS FOR THE TREATMENT OF HIV

TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA

Imidazopiperazine inhibitors of transcription activating proteins

INTRANASAL DHE FOR THE TREATMENT OF HEADACHE

METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK

Liquid oral formulations for sildenafil

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

HTT modulators for treating Huntington's disease

CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY

METHODS FOR TREATING ERECTILE DYSFUNCTION WITH A CGMP-SPECIFIC PHOSPHODIESTERASE 5 INHIBITOR PHARMACEUTICAL COMPOSITION

PDE5 DERIVED REGULATORY CONSTRUCTS AND METHODS OF USE IN IMMUNOTHERAPY

THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIES

PERIPHERALLY ACTING CANNABIDIOL (CBD)-CONTAINING COMPOUNDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS

KRAS G12C inhibitors and methods of using the same

BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION

Oral gliptin compositions and method for preparation thereof

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof

ENHANCER OF PHOTODYNAMIC EFFECT IN ALA-PDT OR ALA-PDD

Novel Ferroportin Inhibitors

Synergistic Combinations of Amino Acid Depletion Agent Sensitizers (AADAS) and Amino Acid Depletion Agents (AADA), and Therapeutic Methods of Use Thereof

TREATMENT OF TACHYCARDIA

NOVEL METHODS

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

CGAS antagonist compounds

SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF

Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

Method for treating HIV with Cabotegravir and Rilpivirine

Use of a DPP-4 inhibitor in SIRS and/or sepsis

Drug delivery system

ANTIVIRAL PRODRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF

COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITES

INHIBITORS OF CBL-B AND METHODS OF USE THEREOF

Modulators of BCL6 proteolysis and associated methods of use

SOTORASIB DOSING REGIMEN

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

POWDER FOR ORAL SUSPENSION CONTAINING TADALAFIL

TRICYCLIC COMPOUNDS AND THEIR USE

Amorphous solid dispersions

SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE

INHIBITING APE2 EXPRESSION IN A SUBJECT TREATED WITH A DRUG AGENT THAT CAUSES INCREASED APE2 EXPRESSION

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

IRAK4 KINASE INHIBITOR AND PREPARATION METHOD THEREFOR

PROTECTION OF OXYGEN SENSITIVE COMPOUNDS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereof